These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The Ernst W. Bertner Memorial Award lecture: the evolution of biological heterogeneity in metastatic neoplasms. Fidler IJ Symp Fundam Cancer Res; 1983; 36():5-26. PubMed ID: 6382521 [TBL] [Abstract][Full Text] [Related]
4. Testing clonality of three and more tumors using their loss of heterozygosity profiles. Ostrovnaya I Stat Appl Genet Mol Biol; 2012 Jul; 11(4):. PubMed ID: 22850066 [TBL] [Abstract][Full Text] [Related]
5. Critical determinants of metastasis. Fidler IJ Semin Cancer Biol; 2002 Apr; 12(2):89-96. PubMed ID: 12027580 [TBL] [Abstract][Full Text] [Related]
6. [Tumor genetic heterogeneity]. Yang YL; Chu JY; Wang MR Yi Chuan; 2013 Jan; 35(1):1-9. PubMed ID: 23357259 [TBL] [Abstract][Full Text] [Related]
7. Adapting clinical paradigms to the challenges of cancer clonal evolution. Murugaesu N; Chew SK; Swanton C Am J Pathol; 2013 Jun; 182(6):1962-71. PubMed ID: 23708210 [TBL] [Abstract][Full Text] [Related]
8. Cancer stem cells: a step toward the cure. Boman BM; Wicha MS J Clin Oncol; 2008 Jun; 26(17):2795-9. PubMed ID: 18539956 [No Abstract] [Full Text] [Related]
9. The reverse evolution from multicellularity to unicellularity during carcinogenesis. Chen H; Lin F; Xing K; He X Nat Commun; 2015 Mar; 6():6367. PubMed ID: 25751731 [TBL] [Abstract][Full Text] [Related]
10. A molecular signature of metastasis in primary solid tumors. Ramaswamy S; Ross KN; Lander ES; Golub TR Nat Genet; 2003 Jan; 33(1):49-54. PubMed ID: 12469122 [TBL] [Abstract][Full Text] [Related]
11. Modulation of cell death in the tumor microenvironment. Wouters BG; Koritzinsky M; Chiu RK; Theys J; Buijsen J; Lambin P Semin Radiat Oncol; 2003 Jan; 13(1):31-41. PubMed ID: 12520462 [TBL] [Abstract][Full Text] [Related]
12. Dynamic alterations of the extracellular environment of ovarian surface epithelial cells in premalignant transformation, tumorigenicity, and metastasis. Capo-Chichi CD; Smith ER; Yang DH; Roland IH; Vanderveer L; Cohen C; Hamilton TC; Godwin AK; Xu XX Cancer; 2002 Oct; 95(8):1802-15. PubMed ID: 12365030 [TBL] [Abstract][Full Text] [Related]
13. Cytogenetic analysis of tumor clonality. Teixeira MR; Heim S Adv Cancer Res; 2011; 112():127-49. PubMed ID: 21925303 [TBL] [Abstract][Full Text] [Related]
14. Adaptation versus selection: the origins of metastatic behavior. Scheel C; Onder T; Karnoub A; Weinberg RA Cancer Res; 2007 Dec; 67(24):11476-9; discussion 11479-80. PubMed ID: 18089773 [No Abstract] [Full Text] [Related]
16. [The role of glycosphingolipids in the expression of neoplastic phenotype. III. Changes in glycosphingolipids related to the capacity of neoplastic cells for metastasis and tumor growth in vivo]. Ugorski M Postepy Hig Med Dosw; 1992; 46(2):191-208. PubMed ID: 1470581 [TBL] [Abstract][Full Text] [Related]
17. Tumor heterogeneity, clonal evolution, and therapy resistance: an opportunity for multitargeting therapy. Calderwood SK Discov Med; 2013 Mar; 15(82):188-94. PubMed ID: 23545047 [TBL] [Abstract][Full Text] [Related]
18. Microenvironment in metastasis: roadblocks and supportive niches. Pein M; Oskarsson T Am J Physiol Cell Physiol; 2015 Nov; 309(10):C627-38. PubMed ID: 26377313 [TBL] [Abstract][Full Text] [Related]
19. Transcription factors: their potential as targets for an individualized therapeutic approach to cancer. Mees C; Nemunaitis J; Senzer N Cancer Gene Ther; 2009 Feb; 16(2):103-12. PubMed ID: 18846113 [TBL] [Abstract][Full Text] [Related]
20. Determination of clonality of metastasis by cell-specific color-coded fluorescent-protein imaging. Yamamoto N; Yang M; Jiang P; Xu M; Tsuchiya H; Tomita K; Moossa AR; Hoffman RM Cancer Res; 2003 Nov; 63(22):7785-90. PubMed ID: 14633704 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]